Proteomics
Discover the early-stage Proteomics ecosystem: investors, accelerators, incubators, fellowships, grants, and global hubs powering next-gen Proteomics startups.
Discover the early-stage Proteomics ecosystem: investors, accelerators, incubators, fellowships, grants, and global hubs powering next-gen Proteomics startups.
Scouts
Share promising startups in this sector and get rewarded if they raise. No prior track record needed.
Investors
Access qualified startups curated by Superscout across pre-seed to seed.
Supporters
Work at a company, lab, or city? Connect with builders in your space.
Proteomics studies the complete set of proteins expressed by a cell, tissue, or organism, providing a more dynamic and functional view of biology than genomics alone. While the genome is essentially fixed, the proteome changes continuously in response to disease, environment, and treatment, making it a richer source of diagnostic and therapeutic insight. Mass spectrometry-based proteomics can now measure thousands of proteins simultaneously, and newer affinity-based platforms (SomaScan, Olink) provide high-throughput protein measurement at lower cost. The sector serves drug target discovery (identifying disease-relevant proteins), diagnostic development (protein biomarkers for disease detection), companion diagnostics (predicting treatment response), and the emerging category of multi-omic integration (combining proteomic data with genomics, metabolomics, and clinical data for comprehensive patient profiling).